High LAIR-1 serum levels were associated with hormone receptor positivity, early tumor stages, and non-diabetic status, as shown in Table 2, and Figure S3 presents significant associations between LAIR-1 serum levels (low and high) and clinicopathological variables in BC patients (n = 90). This evidence concerns the gene NR4A1 and neoplasm.